Ionis Pharmaceuticals, Inc.
General ticker "IONS" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $6.6B (TTM average)
Ionis Pharmaceuticals, Inc. follows the US Stock Market performance with the rate: 54.2%.
Estimated limits based on current volatility of 1.4%: low 81.50$, high 83.82$
Factors to consider:
- Total employees count: 1069 as of 2024
- Top business risk factors: Commercialization challenges, Operational and conduct risks, Supply chain disruptions, Product liability, Labor/talent shortage/retention
Short-term IONS quotes
Long-term IONS plot
Financial data
| YTD | 2022-12-31 | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Operating Revenue | $587.37MM | $787.65MM | $705.14MM |
| Operating Expenses | $997.56MM | $1,141.38MM | $1,180.22MM |
| Operating Income | $-410.19MM | $-353.73MM | $-475.08MM |
| Non-Operating Income | $152.21MM | $19.77MM | $15.01MM |
| Interest Expense | $8.12MM | $12.66MM | $16.99MM |
| R&D Expense | $833.15MM | $899.62MM | $901.53MM |
| Income(Loss) | $-257.99MM | $-333.96MM | $-460.07MM |
| Taxes | $11.74MM | $32.32MM | $-6.17MM |
| Profit(Loss)* | $-269.72MM | $-366.29MM | $-453.90MM |
| Stockholders Equity | $572.89MM | $386.69MM | $600.00MM |
| Inventory | $22.03MM | $7.44MM | $12.51MM |
| Assets | $2,533.88MM | $2,990.07MM | $3,003.68MM |
| Operating Cash Flow | $-274.37MM | $-307.51MM | $-500.95MM |
| Capital expenditure | $20.10MM | $28.01MM | $45.28MM |
| Investing Cash Flow | $-262.64MM | $-214.13MM | $-134.03MM |
| Financing Cash Flow | $-55.30MM | $644.08MM | $478.06MM |
| Earnings Per Share** | $-1.90 | $-2.56 | $-3.04 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.